In a recent study published in the Expert Review of Medical Devices, researchers investigated the utilization of patent term extensions (PTEs) to extend regulatory timeframes for medical devices in the…
Source
Underutilized Opportunities: Exploring Patent Term Extensions for Medical Devices Read Post »
Annual Drug Patent Expirations for VYONDYS+53 Vyondys 53 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…
Source
Annual Drug Patent Expirations for VASCEPA Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers. There are seventy patents…
Source
Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two NDAs. It is available from one supplier. There are nine…
Source
Brivaracetam is the generic ingredient in two branded drugs marketed by Ucb Inc, Aurobindo Pharma Ltd, Lupin Ltd, Sunshine, and Zydus Pharms and, and is included in seven NDAs. There…
Source
New tentative approval for Annora Pharma drug brivaracetam Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five…
Source
New tentative approval for MSN drug dabigatran etexilate mesylate Read Post »
This chart shows the drugs with the most patents in Poland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
Source
Which pharmaceutical drugs have the most drug patents in Poland? Read Post »
ILEVRO (nepafenac) Harrow eye Patent: 7,947,295 Expiration: Jun 8, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
Source
Drug Patent Expirations for the Week of June 2, 2024 Read Post »
Brivaracetam is the generic ingredient in two branded drugs marketed by Ucb Inc, Aurobindo Pharma Ltd, Lupin Ltd, Sunshine, and Zydus Pharms and, and is included in seven NDAs. There…
Source
New tentative approval for Annora Pharma drug brivaracetam Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five…
Source
New tentative approval for MSN drug dabigatran etexilate mesylate Read Post »
Get new actionable insights and updates from BiotechBlog
